- Lobbying
- Dave AND Boyer
Lobbying Arrangements Results for 'Dave Boyer'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Provide counsel and strategic guidance on potential changes to CMS regulations. |
Executive Health Resources
|
Barbour Griffith & Rogers, LLC d/b/a BGR Holding | |||
Details Issues pertaining to regulations on food manufacturing |
The Jel Sert Company
|
BGR Government Affairs | |||
Details 340B drug discount program |
Johnson & Johnson
|
BGR Government Affairs | |||
Details Judiciary issues |
McKenzie & Hart
|
BGR Government Affairs | |||
Details Provide advice, counsel, and as appropriate direct advocacy services related to public policies impacting the biopharmaceutical industry generally, and Pernixs priorities and product portfolio spec... |
Pernix Therapeutics
|
BGR Government Affairs | |||
Details Federal legislation pertaining to prescription drug abuse/utilization of abuse deterrent technology |
Egalet Corporation
|
BGR Government Affairs | |||
Details Provide guidance and strategic counsel with regard to DEA scheduling of FDA approved products. |
DEA Scheduling Coalition (Informal Coalition)
|
BGR Government Affairs | |||
Details Provide guidance and strategic counsel with regard to pending healthcare legislation and the potential impact on the biopharmaceutical industry. |
Millennium: The Takeda Oncology Company
|
Barbour Griffith & Rogers, LLC d/b/a BGR Holding | |||
Details Provide assistance related to health data issues. |
IMS Government Solutions, Inc.
|
Barbour Griffith & Rogers, LLC d/b/a BGR Holding | |||
Details Health Care Reform Legislation; PPACA |
Revere America
|
Barbour Griffith & Rogers, LLC d/b/a BGR Holding | |||
Details Provide strategic advice and counsel on legislative or regulatory actions that could impact the biopharmaceutical industry |
Karyopharm Therapeutics Inc.,
|
BGR Government Affairs | |||
Details Provide guidance and strategic counsel on federal regulatory policy and legislative issues affecting Chelsea's products. |
Chelsea Therapeutics
|
Barbour Griffith & Rogers, LLC d/b/a BGR Holding | |||
Details Health Care Reform Legislation; Provide gudiance and strategic counsel on energy related issues |
Partnership for America
|
Barbour Griffith & Rogers, LLC d/b/a BGR Holding | |||
Details Provide gudiance and strategic counsel on Special Needs Plans with Medicare; Medicare Advantage risk adjustment and new enrollee model. |
XL HEALTH
|
Barbour Griffith & Rogers, LLC d/b/a BGR Holding | |||
Details Provide strategic guidance and counsel on issues impacting the Company. |
Anheuser-Busch Companies
|
BGR Government Affairs | |||
Details Provide guidance and strategic counsel with regard to pending healthcare legislation and the potential impact on the biopharmaceutical industry; Medicare Part D; DEA scheduling of FDA approved prod... |
Eisai Inc.
|
BGR Government Affairs | |||
Details Provide guidance and strategic counsel with regard to regulations and legislation that could impact the biopharmaceutical industry generally, and/ Celgene specifically |
Celgene Corporation
|
BGR Government Affairs | |||
Details Strategic guidance and counsel on regulations and legislations related to NJOY products and business interests. |
NJOY, LLC
|
BGR Government Affairs | |||
Details Health IT; physician fee schedule update; implementation of health care reform; state exchanges; third party payer exchanges |
AAPAN
|
BGR Government Affairs | |||
Details Counsel and gudiance on federal legislation or regulations that may impact proprietary post-secondary education |
American Career College
|
BGR Government Affairs | |||
Details Provide guidance and strategic counsel with regard to regulations and legislation that could impact, pharmaceutical and biotechnology manufacturers. |
Genentech, Inc.
|
BGR Government Affairs | |||
Details Provide guidance and strategic counsel with regard to regulations and legislation that could impact the gene therapies, drug pricing and other issues that impact the industry generally, and bluebir... |
bluebird bio
|
BGR Government Affairs | |||
Details Provide monitoring, analysis, advise and support services related to legislative and administrative policies impacting the tobacco industry |
RAI Services Company
|
BGR Government Affairs | |||
Details Monitor, advise, and as appropriate directly advocate on healthcare and tax policy issues related to Allergan specifically and the lifesciences industry generally. |
Allergan, Inc.
|
Barbour Griffith & Rogers, LLC d/b/a BGR Holding | |||
Details Provide guidance and strategic counsel with regard to regulations and legislation that could impact the biopharmaceutical industry generally, and/ Sobi North America specifically. |
Sobi North America
|
BGR Government Affairs | |||
Details Advise client on legislative and administrative policy-making related to the biopharmaceutical industry generally, and client priorities specifically. Includes raising awareness amongst public offi... |
Roivant Sciences, Inc.
|
BGR Government Affairs | |||
Details Provide guidance and strategic counsel with regard to pending healthcare legislation and the potential impact on the biopharmaceutical industry; Ryan White Care Act reauthorization; Hepatitis C pol... |
Gilead Sciences, Inc.
|
BGR Government Affairs | |||
Details Federal legislation pertaining to medical and pharmaceutical product distribution and medical device manufacturing |
Cardinal Health
|
BGR Government Affairs | |||
Details Provide guidance and strategic counsel with regard to regulations and legislation that could impact the pharmaceutical industry generally, and/ Merck specifically |
Merck & Co., Inc.
|
BGR Government Affairs | |||
Details Counsel and guidance on repealing Section 6001 of PPACA |
Physician Hospitals of America
|
BGR Government Affairs | |||
Details Advise client on legislative and administrative policy-making related to the bio-pharmaceutical industry generally, and client priorities specifically. Includes FDA and CMS related matters, as well... |
Avanir Pharmaceuticals, Inc.
|
BGR Government Affairs | |||
Details Provide strategic guidance and counsel on potential changes to FDA regulations |
Flexion Therapeutics, Inc.
|
BGR Government Affairs | |||
Details Provide guidance and strategic counsel with regard to regulations and legislation that could impact the pharmaceutical industry generally, and Amarin Pharm Inc. specifically |
Amarin Pharm Inc.
|
BGR Government Affairs | |||
Details Health reform implementation; health exchanges and essential benefits; DOC Access Act |
National Association of Vision Care Plans
|
BGR Government Affairs | |||
Details Provide strategic guidance and advocacy on potential regulations and/or legislation impacting food innovation |
Impossible Foods Inc.
|
BGR Government Affairs | |||
Details Provide guidance and strategic counsel with regard to regulations and legislation that could impact the biotechnology industry |
Sanofi US Services, Inc.
|
BGR Government Affairs | |||
Details Providing advice, counsel, and services to support the Pharma & Biopharma Outsourcing Association's public policy priorities |
Pharma & Biopharma Outsourcing Association
|
BGR Government Affairs | |||
Details Advise client on legislative and administrative policy-making related to the bio-pharmaceutical industry generally, and client priorities specifically. Includes FDA and CMS related matters, as well... |
Alnylam Pharmaceuticals, Inc.
|
BGR Government Affairs | |||
Details Potential changes to structure and reimbursement for Medicare Part D; H.R.5376 - Inflation Reduction Act of 2022 - issues related to implementation. Regulatory and legislative health care issues im... |
NEUROCRINE BIOSCIENCES, INC
|
in-house lobbying | |||
Details Provide guidance and strategic counsel with regard to regulations and legislation on drug disposal programs. |
DisposeRx, Inc.
|
BGR Government Affairs | |||
Details Medicare coverage for colon cancer screening |
Epigenomics, Inc.
|
BGR Government Affairs | |||
Details Provide guidance and strategic counsel with regard to regulations and legislation that could impact the pharmaceutical industry generally, and Baudax Bio, Inc. specifically. |
Baudax Bio, Inc. (formerly known as Recro Pharma, Inc.)
|
BGR Government Affairs | |||
Details Provide guidance and strategic advice regarding FDA regulation of medical devices, including diagnostic tests |
Advanced Medical Technology Association
|
BGR Government Affairs | |||
Details Provide analysis and strategic advocacy support services to Edwards Lifesciences public policy priorities, including FDA regulatory and CMS coverage and reimbursement issue |
Edward Lifesciences LLC
|
BGR Government Affairs | |||
Details Provide strategic counsel and advocate on issues related to the biopharmaceutical industry generally, and Alkermes, Inc. specifically |
Alkermes, Inc.
Biopharmaceutical company |
BGR Government Affairs | |||
Details Provide guidance and advocacy with regard to regulations and legislation that could impact the pharmaceutical industry generally, and Zogenix specifically. |
Zogenix, Inc.
|
BGR Government Affairs | |||
Details Provide policy analysis, strategic advice and direct advocacy support to Walgreens related to public policy priorities for the retail pharmacy industry |
Walgreen Co.
|
BGR Government Affairs | |||
Details Strategic advice and counsel on issues impacting gene and cell therapy development and access |
American Society of Gene and Cell Therapy
|
BGR Government Affairs | |||
Details Provide lobbying support on key issues and providing intelligence and policy tracking for relevant federal policy developments that could impact the pharmaceutical and medical device industry gener... |
Bayer Corporation
|
BGR Government Affairs | |||
Details Patent reform; Medicare Part-D non-interference legislation; Medicaid rebates; Follow-on biologics; implementation of health care reform; PDUFA; FDA reform; Trade issues |
Eli Lilly & Co, Inc.
|
BGR Government Affairs |